PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and monosomy 7 (CUT&Tag)
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 24 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Myelodysplastic syndromesThis series is part of our curated briefing on it.
- Samples
- 24 samples: 8 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and monosomy 7HemaSphere · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE270760_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1128130 and SRA study SRP515981. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 20 samples.
How we read this: 8 replicated groups read from 24 sample titles; they account for 20 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8351461 OCI-Vehicle
- GSM8351462 OCI-Ve1 OCI-Ve
- GSM8351463 OCI-Ve2 OCI-Ve
- GSM8351464 OCI-DS3201 OCI-DS
- GSM8351465 OCI-DS1 OCI-DS
- GSM8351466 OCI-DS2 OCI-DS
- GSM8351467 YCU-Vehicle
- GSM8351468 YCU-Ve1 YCU-Ve
- GSM8351469 YCU-Ve2 YCU-Ve
- GSM8351470 YCU-DS3201 YCU-DS
- GSM8351471 YCU-DS1 YCU-DS
- GSM8351472 YCU-DS2 YCU-DS
- GSM8351473 FKH-Vehicle
- GSM8351474 FKH-Ve1 FKH-Ve
- GSM8351475 FKH-Ve2 FKH-Ve
- GSM8351476 FKH-DS3201 FKH-DS
- GSM8351477 FKH-DS1 FKH-DS
- GSM8351478 FKH-DS2 FKH-DS
- GSM8351479 Kasu-Vehicle
- GSM8351480 Kasu-Ve1 Kasu-Ve
- GSM8351481 Kasu-Ve2 Kasu-Ve
- GSM8351482 Kasu-DS3201 Kasu-DS
- GSM8351483 Kasu-DS1 Kasu-DS
- GSM8351484 Kasu-DS2 Kasu-DS
- GSE211032 Expression Analysis (RNA-Seq) of adult Myelodysplastic Syndromes (MDS)/Acute Myeloid Leukemia (AML) with isolated monosomy 7 compared to controls 45 samples same disease briefing · shares mds, aml, cut, monosomy
- GSE288862 ScRNA-Seq of Human MDS and AML Bone Marrow Marrow Microenvironment. 3 samples same disease briefing · shares mds, aml
- GSE284647 The genotype-integrated gene expression profile at the single-cell level of bone marrow CD34-positive hematopoietic stem and progenitor cells (HSPCs) from a patient with myelodysplastic neoplasms (MDS) harboring germline and somatic DDX41 variants. 1 samples same disease briefing · shares mds, harboring
- GSE316079 SLF2 and SMC5 dysfunction drives HSC aging and predisposes to MDS, defining a new inherited bone marrow failure syndrome [ATAC-seq] 6 samples same disease briefing · shares mds
- GSE298729 Chromatin accessibility of hematopoietic stem/progenitor cells (HSPCs) derived from MDS patients before and after disease progression 2 samples same disease briefing · shares mds
- GSE264117 Investigating microenvironment in MDS II 503 samples same disease briefing · shares mds
- GSE298020 PU.1-Activated Genomic Regions Define Low-risk MDS Subsets Characterized by Immune Dysregulation and Disease Progression. 493 samples same disease briefing · shares mds
- GSE275000 Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs 104 samples same disease briefing · shares mds
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.